These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 378768)

  • 1. [Effect of ftorafur and 5-fluorouracil on the chromosomes of human tumor cell cultures].
    Sokova OI; Volgareva GM
    Genetika; 1979; 15(5):855-61. PubMed ID: 378768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of the chromosome damaging effect of ftorafur].
    Volgareva GM; Sokova OI; Pogosiants EE
    Genetika; 1977; 13(3):461-7. PubMed ID: 142687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clastogenicity and sister chromatid exchange induction by ftorafur.
    Vrba M; Adámek R; Blasko M; Brezina V; Chrz R; Goetz P; Michalová K; Musilová J; Novotná B; Pogosianz HE; Raposa T; Siracký J; Sokova OI; Thust R; Ujházy V; Volgareva GM
    Neoplasma; 1981; 28(4):397-402. PubMed ID: 6793879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of ftorafur on the chromosomes of normal and tumorous cells of the Djzungarian hamster in vitro].
    Volgareva GM; Sokova OI; Pogosiants EE
    Genetika; 1978 Mar; 14(3):444-8. PubMed ID: 346443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome aberrations and sister chromatid exchanges following exposure of cultured Chinese hamster cells to ftorafur and 5-fluorouracil].
    Sokova OI
    Genetika; 1978 Oct; 14(10):1818-23. PubMed ID: 363505
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ftorafur on the chromosomes of human normal and tumor cells in vitro].
    Volgareva GM; Sokova OI; Pogosiants EE
    Genetika; 1979; 15(1):157-61. PubMed ID: 391642
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of ftorafur and 5-fluorouracil on the chromosomes of normal and tumorous cells in vivo].
    Sokova OI; Volgareva GM
    Vopr Onkol; 1977; 23(2):94-7. PubMed ID: 324124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice.
    Johnson RK; Garibjanian BT; Houchens DP; Kline I; Gaston MR; Syrkin AB; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1335-45. PubMed ID: 797449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations.
    Slovak ML; Hoeltge GA; Trent JM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6646-52. PubMed ID: 3677098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Mertens F; Johansson B; Höglund M; Mitelman F
    Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic analysis and population study in P3HR-1 cell line derived from Burkitt's lymphoma.
    Hoffmannová H
    Neoplasma; 1991; 38(4):385-92. PubMed ID: 1922571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
    Brothman AR; Peehl DM; Patel AM; McNeal JE
    Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene mutation induction by the antitumor preparation ftorafur].
    Volgareva GM; Stavrovskaia AA; Pogosiants EE
    Genetika; 1982 May; 18(5):758-63. PubMed ID: 6807754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
    Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
    Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic studies on a human cecum adenocarcinoma cell line (HCe-8693)].
    Li S; Qian L; Huang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Feb; 16(1):58-62. PubMed ID: 7954969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of amsidine on the evolution of lymphocyte cultures and on the structure of human metaphase chromosomes].
    Turchini MF; Mathe O; Marques-Verdier A; Chassagne J; Perissel B; Bastide P; Malet P; Turchini JP
    C R Seances Soc Biol Fil; 1987; 181(2):211-5. PubMed ID: 2957038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.